Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 77 Pages
Report ld: 5559770
Request Sample
Customized Report
Blood Irradiation Market Size(US$)

CAGR 2026-2032
3.4%
Market Size,2032
USD 129
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Blood Irradiation market size was US$ 102 million in 2025 and is forecast to reach a readjusted size of US$ 129 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients. It is worth noting that cesium and X-ray irradiators are devices dedicated to blood irradiation, usually operated by specialized institutions or departments external to the healthcare facilities that are actually using the irradiated blood (and thus have to purchase it from the irradiation service providers); in contrast, many user facilities already have LINACs and cobalt sources for cancer therapy and other treatments. These units, although they are designed for other purposes, can be used for blood irradiation on a limited basis. For example, a blood bag holder can be placed where a patient would be exposed and the LINAC operated to irradiate the blood instead of a person.
The primary drivers of the blood irradiation market is the rising prevalence of immune-compromised conditions, such as cancer, organ transplant, and autoimmune diseases. These conditions often require blood transfusions, where blood irradiation can prevent transfusion-associated graft-versus-host disease (TA-GVHD). Additionally, advancements in blood irradiation technology and increased healthcare spending globally are boosting market demand. Regulatory agencies in many regions have also established strict guidelines to ensure the safety of blood transfusions, promoting the adoption of blood irradiation equipment in hospitals and blood banks.
A significant challenge for the blood irradiation market is the high cost associated with irradiation equipment and maintenance. These expenses can be prohibitive for smaller healthcare facilities and blood banks, limiting adoption in low-resource settings. Another challenge is the growing availability of alternative methods for blood sterilization and immunomodulation, which compete with blood irradiation. Regulatory barriers and the need for extensive training and specialized staff for handling irradiation equipment further add to the cost and operational complexity, impacting market growth, particularly in developing countries.
Global Blood Irradiation key players include Best Theratronics, Fujifilm, Gilardoni, Gamma-Service, etc. Global top four manufacturers hold a share about 70%. North America is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent. In terms of product, Gamma-ray Blood Irradiation is the largest segment, with a share over 50%. And in terms of application, the largest application is Blood Bank, followed by Hospital, Research Institutions.
The global Blood Irradiation market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Blood Irradiation sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Blood Irradiation manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Blood Irradiation product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Blood Irradiation value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Blood Irradiation Product Scope
1.2 Blood Irradiation by Type
1.2.1 Global Blood Irradiation Sales by Type (2021, 2025 & 2032)
1.2.2 X-ray Blood Irradiation
1.2.3 Gamma-ray Blood Irradiation
1.3 Blood Irradiation by Application
1.3.1 Global Blood Irradiation Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Blood Bank
1.3.3 Hospital
1.3.4 Research Institutions
1.4 Global Blood Irradiation Market Estimates and Forecasts (2021-2032)
1.4.1 Global Blood Irradiation Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Blood Irradiation Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Blood Irradiation Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Blood Irradiation Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Blood Irradiation Historical Market Scenario by Region (2021-2026)
2.2.1 Global Blood Irradiation Sales Market Share by Region (2021-2026)
2.2.2 Global Blood Irradiation Revenue Market Share by Region (2021-2026)
2.3 Global Blood Irradiation Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Blood Irradiation Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Blood Irradiation Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Blood Irradiation Market Size and Prospects (2021-2032)
2.4.2 Europe Blood Irradiation Market Size and Prospects (2021-2032)
2.4.3 China Blood Irradiation Market Size and Prospects (2021-2032)
2.4.4 Japan Blood Irradiation Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Blood Irradiation Historical Market Review by Type (2021-2026)
3.1.1 Global Blood Irradiation Sales by Type (2021-2026)
3.1.2 Global Blood Irradiation Revenue by Type (2021-2026)
3.1.3 Global Blood Irradiation Average Price by Type (2021-2026)
3.2 Global Blood Irradiation Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Blood Irradiation Sales Forecast by Type (2027-2032)
3.2.2 Global Blood Irradiation Revenue Forecast by Type (2027-2032)
3.2.3 Global Blood Irradiation Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Blood Irradiation
4 Global Market Size by Application
4.1 Global Blood Irradiation Historical Market Review by Application (2021-2026)
4.1.1 Global Blood Irradiation Sales by Application (2021-2026)
4.1.2 Global Blood Irradiation Revenue by Application (2021-2026)
4.1.3 Global Blood Irradiation Average Price by Application (2021-2026)
4.2 Global Blood Irradiation Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Blood Irradiation Sales Forecast by Application (2027-2032)
4.2.2 Global Blood Irradiation Revenue Forecast by Application (2027-2032)
4.2.3 Global Blood Irradiation Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Blood Irradiation Applications
5 Competition Landscape by Players
5.1 Global Blood Irradiation Sales by Player (2021-2026)
5.2 Global Top Blood Irradiation Players by Revenue (2021-2026)
5.3 Global Blood Irradiation Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Blood Irradiation revenue as of 2025
5.4 Global Blood Irradiation Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Blood Irradiation, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Blood Irradiation, Product Type & Application
5.7 Global Key Manufacturers of Blood Irradiation, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Blood Irradiation Sales by Company
6.1.1.1 North America Blood Irradiation Sales by Company (2021-2026)
6.1.1.2 North America Blood Irradiation Revenue by Company (2021-2026)
6.1.2 North America Blood Irradiation Sales Breakdown by Type (2021-2026)
6.1.3 North America Blood Irradiation Sales Breakdown by Application (2021-2026)
6.1.4 North America Blood Irradiation Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Blood Irradiation Sales by Company
6.2.1.1 Europe Blood Irradiation Sales by Company (2021-2026)
6.2.1.2 Europe Blood Irradiation Revenue by Company (2021-2026)
6.2.2 Europe Blood Irradiation Sales Breakdown by Type (2021-2026)
6.2.3 Europe Blood Irradiation Sales Breakdown by Application (2021-2026)
6.2.4 Europe Blood Irradiation Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Blood Irradiation Sales by Company
6.3.1.1 China Blood Irradiation Sales by Company (2021-2026)
6.3.1.2 China Blood Irradiation Revenue by Company (2021-2026)
6.3.2 China Blood Irradiation Sales Breakdown by Type (2021-2026)
6.3.3 China Blood Irradiation Sales Breakdown by Application (2021-2026)
6.3.4 China Blood Irradiation Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Blood Irradiation Sales by Company
6.4.1.1 Japan Blood Irradiation Sales by Company (2021-2026)
6.4.1.2 Japan Blood Irradiation Revenue by Company (2021-2026)
6.4.2 Japan Blood Irradiation Sales Breakdown by Type (2021-2026)
6.4.3 Japan Blood Irradiation Sales Breakdown by Application (2021-2026)
6.4.4 Japan Blood Irradiation Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Best Theratronics
7.1.1 Best Theratronics Company Information
7.1.2 Best Theratronics Business Overview
7.1.3 Best Theratronics Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Best Theratronics Blood Irradiation Products Offered
7.1.5 Best Theratronics Recent Development
7.2 Fujifilm
7.2.1 Fujifilm Company Information
7.2.2 Fujifilm Business Overview
7.2.3 Fujifilm Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Fujifilm Blood Irradiation Products Offered
7.2.5 Fujifilm Recent Development
7.3 Gilardoni
7.3.1 Gilardoni Company Information
7.3.2 Gilardoni Business Overview
7.3.3 Gilardoni Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Gilardoni Blood Irradiation Products Offered
7.3.5 Gilardoni Recent Development
7.4 Eckert & Ziegler
7.4.1 Eckert & Ziegler Company Information
7.4.2 Eckert & Ziegler Business Overview
7.4.3 Eckert & Ziegler Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Eckert & Ziegler Blood Irradiation Products Offered
7.4.5 Eckert & Ziegler Recent Development
7.5 Actemium
7.5.1 Actemium Company Information
7.5.2 Actemium Business Overview
7.5.3 Actemium Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Actemium Blood Irradiation Products Offered
7.5.5 Actemium Recent Development
7.6 WEGO (Rad Source)
7.6.1 WEGO (Rad Source) Company Information
7.6.2 WEGO (Rad Source) Business Overview
7.6.3 WEGO (Rad Source) Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.6.4 WEGO (Rad Source) Blood Irradiation Products Offered
7.6.5 WEGO (Rad Source) Recent Development
7.7 Shinva Medical
7.7.1 Shinva Medical Company Information
7.7.2 Shinva Medical Business Overview
7.7.3 Shinva Medical Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Shinva Medical Blood Irradiation Products Offered
7.7.5 Shinva Medical Recent Development
7.8 LIVZON
7.8.1 LIVZON Company Information
7.8.2 LIVZON Business Overview
7.8.3 LIVZON Blood Irradiation Sales, Revenue and Gross Margin (2021-2026)
7.8.4 LIVZON Blood Irradiation Products Offered
7.8.5 LIVZON Recent Development
8 Blood Irradiation Manufacturing Cost Analysis
8.1 Blood Irradiation Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Blood Irradiation
8.4 Blood Irradiation Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Blood Irradiation Distributors List
9.3 Blood Irradiation Customers
10 Blood Irradiation Market Dynamics
10.1 Blood Irradiation Industry Trends
10.2 Blood Irradiation Market Drivers
10.3 Blood Irradiation Market Challenges
10.4 Blood Irradiation Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Blood Irradiation market was valued at US$ 102 million in 2025 and is anticipated to reach US$ 129 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 111
USD 2900.00
(Single User License)
The global market for Blood Irradiation was estimated to be worth US$ 102 million in 2025 and is projected to reach US$ 129 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
The global market for Blood Irradiation was estimated to be worth US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 96
USD 3950.00
(Single User License)
The global Blood Irradiation market is projected to grow from US$ 95.6 million in 2024 to US$ 125 million by 2031, at a CAGR of 3.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 134
USD 4900.00
(Single User License)
In 2024, the global market size of Blood Irradiation was estimated to be worth US$ 95.6 million and is forecast to reach approximately US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 136
USD 5900.00
(Single User License)
Valued at US$ 102 million in 2024, the global Blood Irradiation market is forecast to reach US$ 125 million by 2030, at a CAGR of 3.4% during the forecast period.
Published Date: 2025-03-23
Pages: 134
USD 4900.00
(Single User License)
The global Blood Irradiation market size was US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-03-23
Pages: 77
USD 4250.00
(Single User License)
The global market for Blood Irradiation was valued at US$ 95.6 million in the year 2024 and is projected to reach a revised size of US$ 125 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-03-23
Pages: 80
USD 2900.00
(Single User License)
The global market for Blood Irradiation was estimated to be worth US$ 70.3 million in 2024 and is forecast to a readjusted size of US$ 127 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 97
USD 3950.00
(Single User License)
Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients.
Published Date: 2024-04-17
Pages: 158
USD 5600.00
(Single User License)
The global Blood Irradiation market was valued at US$ 102 million in 2025 and is anticipated to reach US$ 129 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 111
The global market for Blood Irradiation was estimated to be worth US$ 102 million in 2025 and is projected to reach US$ 129 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
The global market for Blood Irradiation was estimated to be worth US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 96
The global Blood Irradiation market is projected to grow from US$ 95.6 million in 2024 to US$ 125 million by 2031, at a CAGR of 3.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 134
In 2024, the global market size of Blood Irradiation was estimated to be worth US$ 95.6 million and is forecast to reach approximately US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 136
Valued at US$ 102 million in 2024, the global Blood Irradiation market is forecast to reach US$ 125 million by 2030, at a CAGR of 3.4% during the forecast period.
Published: 2025-03-23
Pages: 134
The global Blood Irradiation market size was US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-03-23
Pages: 77
The global market for Blood Irradiation was valued at US$ 95.6 million in the year 2024 and is projected to reach a revised size of US$ 125 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-03-23
Pages: 80
The global market for Blood Irradiation was estimated to be worth US$ 70.3 million in 2024 and is forecast to a readjusted size of US$ 127 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 97
Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients.
Published: 2024-04-17
Pages: 158
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now